Last week, the FDA has approved Latisse, the first drug to promote eyelash growth, according to Allergan, the company that makes Latisse. Latisse, which will be available by prescription starting in the first quarter of 2009, contains the active ingredient of the glaucoma drug Lumigan, which is also made by Allergan.
Eyelash growth is a known side effect of Lumigan. But Lumigan and Latisse are used differently. Lumigan is an eyedrop, and Latisse gets dabbed along the lash line, much like mascara,on the upper eyelids to promote longer, thicker, darker lashes.
Allergan states that “Latisse users can expect to experience longer, fuller, and darker eyelashes in as little as eight weeks, with full results in 16 weeks.” If Latisse is stopped, eyelashes will gradually return to their previous appearance as new eyelashes grow in.
TAKE HOME MESSAGE: Latisse will be available for prescription at OCLI within the next month or so for the treatment of eyelash thinning. It will take a few weeks for effectiveness to be seen, and will need to be maintained to keep eyelashes full.
Our world-class team of professionals at OCLI can help you with the latest treatment options for you.
Schedule an appointment
Are you a new patient? *
Start your search. Search by location or provider.
Please choose your preferred provider: *
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Self-scheduling is not currently available for this provider, please complete form below and a member of the OCLI Vision team will contact you to schedule your appointment.
The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia and specialize in primary vision care, LASIK, cataract surgery, glaucoma, diabetic eye care, and other services for patients in the Northeast.
These locations include practice locations of OCLI Vision as well as the practice locations of other vision services providers and ambulatory surgery centers supported by the administrative services of Spectrum Vision Partners. Each location is identified by the vision service provider or company operating at the location.